The Wisconsin Breast Cancer Epidemiology Simulation Model
- PMID: 17032893
- DOI: 10.1093/jncimonographs/lgj007
The Wisconsin Breast Cancer Epidemiology Simulation Model
Abstract
The Wisconsin Breast Cancer Epidemiology Simulation Model is a discrete-event, stochastic simulation model using a systems-science modeling approach to replicate breast cancer incidence and mortality in the U.S. population from 1975 to 2000. Four interacting processes are modeled over time: (1) natural history of breast cancer, (2) breast cancer detection, (3) breast cancer treatment, and (4) competing cause mortality. These components form a complex interacting system simulating the lives of 2.95 million women (approximately 1/50 the U.S. population) from 1950 to 2000 in 6-month cycles. After a "burn in" of 25 years to stabilize prevalent occult cancers, the model outputs age-specific incidence rates by stage and age-specific mortality rates from 1975 to 2000. The model simulates occult as well as detected disease at the individual level and can be used to address "What if?" questions about effectiveness of screening and treatment protocols, as well as to estimate benefits to women of specific ages and screening histories.
Similar articles
-
The SPECTRUM population model of the impact of screening and treatment on U.S. breast cancer trends from 1975 to 2000: principles and practice of the model methods.J Natl Cancer Inst Monogr. 2006;(36):47-55. doi: 10.1093/jncimonographs/lgj008. J Natl Cancer Inst Monogr. 2006. PMID: 17032894
-
A stochastic simulation model of U.S. breast cancer mortality trends from 1975 to 2000.J Natl Cancer Inst Monogr. 2006;(36):86-95. doi: 10.1093/jncimonographs/lgj012. J Natl Cancer Inst Monogr. 2006. PMID: 17032898
-
Modeling the impact of treatment and screening on U.S. breast cancer mortality: a Bayesian approach.J Natl Cancer Inst Monogr. 2006;(36):30-6. doi: 10.1093/jncimonographs/lgj006. J Natl Cancer Inst Monogr. 2006. PMID: 17032892
-
Additional common inputs for analyzing impact of adjuvant therapy and mammography on U.S. mortality.J Natl Cancer Inst Monogr. 2006;(36):26-9. doi: 10.1093/jncimonographs/lgj005. J Natl Cancer Inst Monogr. 2006. PMID: 17032891 Review.
-
Modeling the impact of adjuvant therapy and screening mammography on U.S. breast cancer mortality between 1975 and 2000: introduction to the problem.J Natl Cancer Inst Monogr. 2006;(36):2-6. doi: 10.1093/jncimonographs/lgj002. J Natl Cancer Inst Monogr. 2006. PMID: 17032887 Review. No abstract available.
Cited by
-
Microsimulation Modeling in Oncology.JCO Clin Cancer Inform. 2018 Dec;2:1-11. doi: 10.1200/CCI.17.00029. JCO Clin Cancer Inform. 2018. PMID: 30652551 Free PMC article. Review.
-
Cost-effectiveness of mammography from a publicly funded health care system perspective.CMAJ Open. 2018 Feb 8;6(1):E77-E86. doi: 10.9778/cmajo.20170106. CMAJ Open. 2018. PMID: 29440151 Free PMC article.
-
Modelling mammography screening for breast cancer in the Canadian context: Modification and testing of a microsimulation model.Health Rep. 2015 Dec;26(12):3-8. Health Rep. 2015. PMID: 26676233 Free PMC article.
-
Using Collaborative Simulation Modeling to Develop a Web-Based Tool to Support Policy-Level Decision Making About Breast Cancer Screening Initiation Age.MDM Policy Pract. 2017 Jul;2(2):2381468317717982. doi: 10.1177/2381468317717982. Epub 2017 Jul 8. MDM Policy Pract. 2017. PMID: 29376135 Free PMC article.
-
Cost-effectiveness of digital mammography breast cancer screening.Ann Intern Med. 2008 Jan 1;148(1):1-10. doi: 10.7326/0003-4819-148-1-200801010-00002. Ann Intern Med. 2008. PMID: 18166758 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical